Cargando…
Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402298/ https://www.ncbi.nlm.nih.gov/pubmed/32650586 http://dx.doi.org/10.3390/ijms21144827 |
_version_ | 1783566727991263232 |
---|---|
author | Sánchez-Gloria, José L. Osorio-Alonso, Horacio Arellano-Buendía, Abraham S. Carbó, Roxana Hernández-Díazcouder, Adrián Guzmán-Martín, Carlos A. Rubio-Gayosso, Ivan Sánchez-Muñoz, Fausto |
author_facet | Sánchez-Gloria, José L. Osorio-Alonso, Horacio Arellano-Buendía, Abraham S. Carbó, Roxana Hernández-Díazcouder, Adrián Guzmán-Martín, Carlos A. Rubio-Gayosso, Ivan Sánchez-Muñoz, Fausto |
author_sort | Sánchez-Gloria, José L. |
collection | PubMed |
description | Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms. |
format | Online Article Text |
id | pubmed-7402298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74022982020-08-07 Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension Sánchez-Gloria, José L. Osorio-Alonso, Horacio Arellano-Buendía, Abraham S. Carbó, Roxana Hernández-Díazcouder, Adrián Guzmán-Martín, Carlos A. Rubio-Gayosso, Ivan Sánchez-Muñoz, Fausto Int J Mol Sci Review Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms. MDPI 2020-07-08 /pmc/articles/PMC7402298/ /pubmed/32650586 http://dx.doi.org/10.3390/ijms21144827 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sánchez-Gloria, José L. Osorio-Alonso, Horacio Arellano-Buendía, Abraham S. Carbó, Roxana Hernández-Díazcouder, Adrián Guzmán-Martín, Carlos A. Rubio-Gayosso, Ivan Sánchez-Muñoz, Fausto Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title | Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title_full | Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title_fullStr | Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title_full_unstemmed | Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title_short | Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension |
title_sort | nutraceuticals in the treatment of pulmonary arterial hypertension |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402298/ https://www.ncbi.nlm.nih.gov/pubmed/32650586 http://dx.doi.org/10.3390/ijms21144827 |
work_keys_str_mv | AT sanchezgloriajosel nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT osorioalonsohoracio nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT arellanobuendiaabrahams nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT carboroxana nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT hernandezdiazcouderadrian nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT guzmanmartincarlosa nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT rubiogayossoivan nutraceuticalsinthetreatmentofpulmonaryarterialhypertension AT sanchezmunozfausto nutraceuticalsinthetreatmentofpulmonaryarterialhypertension |